BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19952937)

  • 1. MIB-1 (Ki-67), estrogen receptor, progesterone receptor, and p53 expression in atypical cells in uterine symplastic leiomyomas.
    Sun X; Mittal K
    Int J Gynecol Pathol; 2010 Jan; 29(1):51-4. PubMed ID: 19952937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors.
    Mittal K; Demopoulos RI
    Hum Pathol; 2001 Sep; 32(9):984-7. PubMed ID: 11567229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical leiomyomas of the uterus with long-term follow-up after myomectomy with immunohistochemical analysis for p16INK4A, p53, Ki-67, estrogen receptors, and progesterone receptors.
    Sung CO; Ahn G; Song SY; Choi YL; Bae DS
    Int J Gynecol Pathol; 2009 Nov; 28(6):529-34. PubMed ID: 19851199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are there any differences in the expression of hormonal receptors and proliferation markers between uterine and extrauterine leiomyomas?
    Sen N; Demirkan NC; Colakoglu N; Duzcan SE
    Int J Surg Pathol; 2008 Jan; 16(1):43-7. PubMed ID: 18203783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Ki-67, P53 and progesterone receptors in uterine smooth muscle tumors. Diagnostic value.
    Petrović D; Babić D; Forko JI; Martinac I
    Coll Antropol; 2010 Mar; 34(1):93-7. PubMed ID: 20437637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of the effect of raloxifene and gosereline on uterine leiomyoma volume changes and estrogen receptor, progesterone receptor, bcl-2 and p53 expression immunohistochemically in premenopausal women.
    Baytur YB; Ozbilgin K; Cilaker S; Lacin S; Kurtul O; Oruc S; Koyuncu FM
    Eur J Obstet Gynecol Reprod Biol; 2007 Nov; 135(1):94-103. PubMed ID: 16973256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinoma.
    Oreskovic S; Babic D; Kalafatic D; Barisic D; Beketic-Oreskovic L
    Gynecol Oncol; 2004 Apr; 93(1):34-40. PubMed ID: 15047211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of Ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas. A clinicopathologic study.
    Akhan SE; Yavuz E; Tecer A; Iyibozkurt CA; Topuz S; Tuzlali S; Bengisu E; Berkman S
    Gynecol Oncol; 2005 Oct; 99(1):36-42. PubMed ID: 15992918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association of expression of progesterone and estrogen-alpha receptors with the activity of argyrophilic proteins in nucleolar organizer regions in smooth muscle tumors of the corpus uteri].
    Avdalian AM; Bobrov IP; Klimachev VV; Chechulin MN; Lazarev AF
    Arkh Patol; 2009; 71(4):50-3. PubMed ID: 19824432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of 14-3-3 protein family levels and associated receptor expression of estrogen and progesterone in human uterine leiomyomas.
    Wang L; Huang H; Liu D; Fang S; Xian Y; Zhou J; Zuo Y; Wang F; Huang O; He M
    Gynecol Endocrinol; 2012 Aug; 28(8):665-8. PubMed ID: 22329840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid receptors and hormones in relation to cell proliferation and apoptosis in poorly differentiated epithelial ovarian tumors.
    Lindgren P; Bäckström T; Mählck CG; Ridderheim M; Cajander S
    Int J Oncol; 2001 Jul; 19(1):31-8. PubMed ID: 11408919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the expression of estrogen and progesteron receptors, and of PCNA and Ki67 proliferation antigens, in uterine myomata cells in relation to the phase of the menstrual cycle.
    Zasławski R; Surowiak P; Dziegiel P; Pretnik L; Zabel M
    Med Sci Monit; 2001; 7(5):908-13. PubMed ID: 11535933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical study of DNA topoisomerase I, p53, and Ki-67 in uterine carcinosarcomas.
    Lee SJ; Kim HS; Kim HS; Chun YK; Hong SR; Lee JH
    Hum Pathol; 2007 Aug; 38(8):1226-31. PubMed ID: 17490723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis, cellular proliferation and expression of p53 in human uterine leiomyomas and myometrium during the menstrual cycle and after menopause.
    Wu X; Blanck A; Olovsson M; Möller B; Favini R; Lindblom B
    Acta Obstet Gynecol Scand; 2000 May; 79(5):397-404. PubMed ID: 10830768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Estrogen and progesterone receptors in meningiomas: immunohistochemical (Mib-1, p53) and clinico-morphological correlations].
    Taddei GL; Caldarella A; Raspollini MR; Taddei A; Buccoliero AM
    Pathologica; 2002 Feb; 94(1):10-5. PubMed ID: 11912872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progesterone down-regulates insulin-like growth factor-I expression in cultured human uterine leiomyoma cells.
    Yamada T; Nakago S; Kurachi O; Wang J; Takekida S; Matsuo H; Maruo T
    Hum Reprod; 2004 Apr; 19(4):815-21. PubMed ID: 15033949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation of CerbB-2 to Ki-67 and P53 expressions in hormone-independent breast cancer].
    Fang Q; Wang XF
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Feb; 31(2):380-2. PubMed ID: 21354936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications.
    Rudolph P; Olsson H; Bonatz G; Ratjen V; Bolte H; Baldetorp B; Fernö M; Parwaresch R; Alm P
    J Pathol; 1999 Jan; 187(2):207-16. PubMed ID: 10365096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular proliferation, estrogen receptor, progesterone receptor, and bcl-2 expression in GnRH agonist-treated uterine leiomyomas.
    Vu K; Greenspan DL; Wu TC; Zacur HA; Kurman RJ
    Hum Pathol; 1998 Apr; 29(4):359-63. PubMed ID: 9563785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas.
    Amatya VJ; Takeshima Y; Sugiyama K; Kurisu K; Nishisaka T; Fukuhara T; Inai K
    Hum Pathol; 2001 Sep; 32(9):970-5. PubMed ID: 11567227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.